Pay in 4 interest-free payments of $7.07 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Animal studies have reported the intragastric application of 10 g/kg BPC-157 as an effective dose, which is estimated to be equivalent to 1.6 g/kg in humans, based on standard dosage conversions
Compounded versions of this dual agonist, often labeled GLP-1 GIP B12, add a third element: vitamin B12
Viscoelasticity is a measurement of how substances flow and resist force (Lai et al., 2009)
Key Research Areas Gastrointestinal mucosal protection BPC-157 is studied in gut tissue models for its interaction with gastric mucosal repair pathways, including protection against NSAID-induced lesions and inflammatory bowel disease models Tendon and ligament biology Investigated in in-vitro and rodent models for its influence on fibroblast activity, collagen synthesis, and tendon-to-bone attachment repair Angiogenesis Studied for its promotion of VEGF expression and new blood vessel formation in wound healing and ischaemia models Neuroprotection Referenced in studies examining dopamine and serotonin system modulation
US$ 20.48
US$ 29.12
US$ 29.02
US$ 26.37
US$ 20.43
US$ 26.46
